Intervention

Valacyclovir

ClinicalTrials.gov intervention label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov intervention label, found in 12 distinct published trials. Registry interventions may represent drugs, devices, procedures or other study activities. A matched term or study association does not establish product equivalence, efficacy or regulatory approval.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials12
Recruiting2
Common conditions21
Lead sponsors shown10
Advertisement

Clinical trials

12 shown
Aglatimagene Besadenovec + Prodrug and Pembrolizumab vs Docetaxel for Stage IV Non-Squamous NSCLC Progressing on Pembrolizumab (AURORA)NCT07660094 · 2026-06-15
RECRUITING
Phase II High Risk Prostate Cancer Trial Using Gene & Androgen Deprivation Therapies, Radiotherapy, & SurgeryNCT03541928 · 2018-08-02
RECRUITING
Anti-viral Therapy in Alzheimer's DiseaseNCT03282916 · 2018-02-12
COMPLETED
SBRT and Oncolytic Virus Therapy Before Pembrolizumab for Metastatic TNBC and NSCLCNCT03004183 · 2017-07-01
COMPLETED
Trial of Radiation and Gene Therapy Before Nivolumab for Metastatic Non-Small Cell Lung Carcinoma and Uveal MelanomaNCT02831933 · 2017-02-15
TERMINATED
Can Valacyclovir Attenuate Inflammation in Antiretroviral-Treated HIV-Infected Individuals With Herpes Simplex Virus Type 2?NCT01176409 · 2010-09-01
COMPLETED
Examining the Ability of Herpes Simplex Virus Type 2 (HSV2) Therapy to Reduce HIV Target Cell Numbers in the CervixNCT00946556 · 2010-04-01
COMPLETED
An Open-label Trial of the Effect of Valacyclovir on Plasma HIV-1 Levels Among HIV-1 Seropositive and HSV-1/2 Seronegative PersonsNCT01059084 · 2010-01-01
WITHDRAWN
Effect of Valacyclovir in the Reduction of HSV-2 Recurrence and SheddingNCT00803543 · 2009-01-01
COMPLETED
Systematic Evaluation of Antiviral Medication in SchizophreniaNCT00514449 · 2007-06-01
COMPLETED
HSV-2 Suppression to Reduce HIV-1 Levels in HIV-1 Co-infected PersonsNCT00465205 · 2005-01-01
COMPLETED
Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingNCT00158509 · 2004-08-01
COMPLETED

Common conditions

Trial status mix

COMPLETED8
RECRUITING2
TERMINATED1
WITHDRAWN1

Phase mix

PHASE26
NA3
PHASE33
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.